iNCOVACC, a brand-new domestic drug, has been introduced by Bharat Biotech to aid in the fight against COVID 19. The nasal Covid vaccine ha...

The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adul...

The drug regulator has approved Covovax as a heterologous booster dose for adults administered with two doses of Covishield or Covaxin, sou...

"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommended for market authorisation of Covid jab ...

Bharat Biotech has made its intranasal Covid-19 vaccine iNNOVACC available on CoWin, priced at ₹800 per dose for private markets and ₹325 f...

Prakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs ...

Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), had written a letter to the the D...

This is the world's first intranasal vaccine for Covid-19 to receive approval for the primary 2-dose schedule, and as a heterologous booste...

The Central Drugs Standard Control Organisation (CDSCO) gave its nod to the vaccine for use as both primary series as well as a heterologou...

Covaxin - and has submitted the data to the Drugs Controller General of India (DCGI) for the review. Hyderabad based Bharat Biotech has sou...

According to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...

The National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...

The vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...

A study showed that if the booster is the same as the first two doses, it boosts immunity well, but when the booster dose is different, the...

The study aims to discover how a person fully vaccinated with either Covishield or Covaxin responds to a booster of the other vaccine (hete...

The Indian Council of Medical Research's NIE has proposed to conduct phase-2 safety and immunogenicity study specifically on people with co...